Achieved record sales and EBIT for Q2 and H1 2026, with Q2 revenue at NOK 202 million (up 19.5% YoY) and H1 at NOK 403.7 million (up 15.1% YoY), despite negative currency effects.
Own products drove growth, with strong contributions from Americas (up 46.3% currency-neutral in Q2), EMEA, and APAC.
EBIT margin reached 32.3% in Q2 and 30.3% for H1, reflecting strong operational leverage.
Dividend of NOK 8 per share (NOK 146.3 million) paid in May; board proposes quarterly dividends going forward.
Recurring sales remained high at 67–70% of total sales in H1.
Q2 revenue: NOK 202 million (up 19.5% YoY); H1 revenue: NOK 403.7 million (up 15.1% YoY).
Q2 EBIT: NOK 65.3 million (32.3% margin); H1 EBIT: NOK 122.4 million (30.3% margin).
Q2 EBITDA: NOK 71.3 million (35.3% margin); H1 EBITDA: NOK 134.6 million.
Q2 net profit: NOK 52.2 million; H1 net profit: NOK 92.5 million.
Gross margin Q2: 82.2% (up from 81.9%); H1: 80.9% (down from 82.5%).
Updated long-term outlook expects higher growth trajectory and continued margin expansion through 2030, targeting NOK 1 billion annual revenue within a few years.
Growth drivers include new product launches (MiraQ Ultimate, MiraQ Vascular), expanded sales force, and increased clinical adoption.
Significant market opportunity remains, with only 10% of estimated NOK 7 billion market addressed and 40% penetration in CABG procedures.
All projections subject to uncertainty and not formal guidance.
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Search for any keyword across all transcripts simultaneously.
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
The easiest way to stay updated during earnings season.
All events from public companies. Live and recorded.
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Explore our global coverage